Fig. 2

The association of expressions of immune checkpoints with clinical outcomes in patients with RCC. Representative images of kaplan–Meier survival curves of PD-1 expression either in the primary or metastatic tumors in the whole cohort (a-b), PD-L1 expression in the primary tumor (c-d) and PD-L2 expression in the primary tumor (e-f)